ArticleClinical drug investigation2018

Epoetin Biosimilars in the Treatment of Renal Anemia: What Have We Learned from a Decade of European Experience?

David Goldsmith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.